Clinical pathology of Werner syndrome starting from 10 to 20 years of age including early graying, short stature, hair loss, and bilateral cataracts
Preclinical and clinical studies have demonstrated the efficacy of MenSCs in treating infertility, premature ovarian insufficiency, intrauterine adhesions, hepatic disorders, cutaneous injuries, and neurological diseases
Taken together, the findings from preclinical studies in animal models suggest that NAC has the potential for the treatment of chronic neuropathic pain, including diabetic neuropathy
Invasive Gynecol
This progression is driven by hepatocellular inflammation, damage, and subsequent fibrosis (Figure 1) [3]
Incompatibility: Reactivity with other active ingredients or preservatives in complex cosmetic matrices